Results 11 to 20 of about 23,620 (209)

Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan

Arquivos Brasileiros de Cardiologia, 2000
OBJECTIVE: To compare the regression of left ventricular hypertrophy in patients with moderate hypertension treated with enalapril, losartan or a combination of the two drugs at lower doses.
Antônio Carlos Avanza Jr, Lilian Mameri El Aouar, José Geraldo Mill   +2 more
doaj   +2 more sources

Higher persistence with valsartan compared with enalapril in daily practice

Vascular Health and Risk Management, 2008
Satu J Siiskonen1, Nancy S Breekveldt-Postma1, Gábor Vincze2, Zeba M Khan3, Joëlle A Erkens1, Ron MC Herings11PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands; 2Novartis Pharma AG, Basel, Switzerland; 3Novartis ...
Satu J Siiskonen, Nancy S Breekveldt-Postma, Gábor Vincze, Zeba M Khan, Joëlle A Erkens, et al   +5 more
doaj   +1 more source

Enalapril in patients after mitral valve replacement

Кардиоваскулярная терапия и профилактика, 2007
Aim. To assess enalapril effectiveness in myocardial remodeling correction among patients after mitral valve replacement. Material and methods. In total, 54 patients (mean age 46,3±7,6 years) with isolated or prevalent mitral valve stenosis were examined.
O. L. Barbarash, E. V. Tavlueva, Yu. V. Krotikov, I. N. Sizova, L. S. Barbarash   +4 more
doaj   +2 more sources

The endocrine product of renal (preglomerular) contractile pericytes depends on prolyl-4-hydroxylases 2 and 3. [PDF]

J Physiol
Abstract figure legend Preglomerular pericyte‐like SMMHC+ vascular smooth muscle cells (VSMCs) display marked endocrine plasticity. Hypotension caused by salt depletion and angiotensin‐converting enzyme (ACE) inhibition induces a reversible transformation of these VSMCs toward an endocrine state that produces renin.
Firmke BKM, Süß LM, Forst AL, Kurtz A, Broeker KA.   +4 more
europepmc   +2 more sources

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Lowering serum homocysteine in H-type hypertensive patients with atrial fibrillation after radiofrequency catheter ablation to prevent atrial fibrillation recurrence

Frontiers in Nutrition, 2022
BackgroundPrior investigation revealed that elevated serum total homocysteine (tHcy) are strongly correlated with atrial fibrillation (AF) recurrence. Herein, the goal of this study was to elucidate whether folic acid (FA) treatment reduced AF recurrence
Youzheng Dong, Ting Huang, Zhenyu Zhai, Quanbin Dong, Zhen Xia, Zirong Xia, Jianhua Yu, Xinghua Jiang, Kui Hong, Kui Hong, Yanqing Wu, Xiaoshu Cheng, Xiaoshu Cheng, Juxiang Li   +13 more
doaj   +1 more source

COMPARATIVE EFFICACY OF ACE INHIBITORS (RAMIPRIL VS ENALAPRIL) IN TREATMENT OF CHRONIC HEART FAILURE IN WOMEN

Рациональная фармакотерапия в кардиологии, 2016
Aim. To compare clinical and haemodynamic efficacy of ramipril vs enalapril in women with chronic heart failure (CHF).Material and methods. 60 women with non valvular CHF were included in the study.
S. N. Tereshchenko, I. V. Zhirov, E. V. Malichenko, E. E. Kazantseva   +3 more
doaj   +1 more source

Two strategies for arterial hypertension treatment in patients with secondary chronic pyelonephritis

Кардиоваскулярная терапия и профилактика, 2011
Aim. To compare the antihypertensive effectiveness, cardio- and nephroprotection, and metabolic effects of the combinations “enalapril + indapamide” vs. “enalapril + nifedipine slow release (SR)” in patients with arterial hypertension (AH) and secondary ...
M. E. Statsenko, M. V. Derevyanchenko
doaj   +1 more source

A Liquid Chromatography-Tandem Mass Spectrometry Method for Evaluation of Two Brands of Enalapril 20 mg Tablets in Healthy Human Volunteers

Journal of Analytical Methods in Chemistry, 2017
Enalapril is an angiotensin-converting enzyme inhibitor used for treatment of hypertension and chronic heart disease. Enalaprilat is its active metabolite responsible for the activity.
Wael Abu Dayyih, Mohammed Hamad, Ahmad Abu Awwad, Eyad Mallah, Zainab Zakarya, Alice Abu Dayyih, Tawfiq Arafat   +6 more
doaj   +1 more source

A Comparative Study of the Safety and Efficacy of Amlodipine and Enalapril when Prescribed as Monotherapy in Patients with Isolated Systolic Hypertension

Journal of Nobel Medical College, 2023
Background: Most elderly patients with high blood pressure have isolated systolic hypertension. Enalapril and amlodipine are respectively the most commonly prescribed ACE inhibitors and calcium channel blockers in Nepal. The goal of the current study was
Rajesh Yadav, Rekha Shah
doaj   +1 more source